Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (92 total)
-
Créateur: NETEC
Sujet: Emergency Management
Type d'élément: Webinaire
Date de la dernière mise à jour: 2020-12-16
Description: In this webinar, we will discuss the hesitancy surrounding the COVID-19 vaccine including the public fears related to the inconsistencies of risk communication, describe what resources are reliable and available to assist with interpretation of… -
Créateur: NETEC
Sujet: Treatment & Care
Type d'élément: Vidéo
Date de la dernière mise à jour: 2022-09-09
Description: In this video, we demonstrate the technique of intradermal medication administration. In the 2022 monkeypox outbreak, this technique is being used to administer the Jynneos smallpox and monkeypox vaccine in order to increase the number of available… -
Créateur: NIH
Sujet: Infection Control
Type d'élément: Lien hypertexte
Date de la dernière mise à jour: 2020-05-04
Description: This is a phase I, open-label, dose ranging clinical trial in males and non-pregnant females, starting at 18 years of age, inclusive, who are in good health and meet all eligibility criteria. This clinical trial is designed to assess the safety,… -
Créateur: Oxford COVID Vaccine Trial Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-07-20
Description: The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might be curtailed by vaccination. We assessed the safety, reactogenicity, and immunogenicity of a viral vectored coronavirus vaccine that expresses the spike protein of… -
Créateur: Polack, Fernando P., Stephen J. Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L. Perez, Gonzalo Pérez Marc, Edson D. Moreira, Cristiano Zerbini, Ruth Bailey, Kena A. Swanson, Satrajit Roychoudhury, Kenneth Koury,…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-12-10
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe and effective vaccines are needed urgently. -
Créateur: Poland, Gregory A., Inna G. Ovsyannikova, and Richard B. Kennedy.
Sujet: Laboratory
Type d'élément: Publication
Date de la dernière mise à jour: 2020-10-13
Description: Understanding immune responses to severe acute respiratory syndrome coronavirus 2 is crucial to understanding disease pathogenesis and the usefulness of bridge therapies, such as hyperimmune globulin and convalescent human plasma, and to developing… -
Créateur: Pollard, Andrew J., Odile Launay, Jean-Daniel Lelievre, Christine Lacabaratz, Sophie Grande, Neil Goldstein, Cynthia Robinson, Auguste Gaddah, Viki Bockstal, Aurelie Wiedemann, Maarten Leyssen, Kerstin Luhn, Laura Richert, Christine Bétard, Malick M.…
Sujet: Laboratory
Type d'élément: Publication
Date de la dernière mise à jour: 2020-11-17
Description: To address the unmet medical need for an effective prophylactic vaccine against Ebola virus we assessed the safety and immunogenicity of three different two-dose heterologous vaccination regimens with a replication-deficient adenovirus type 26…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: Prendecki, Maria, Candice Clarke, Jonathan Brown, Alison Cox, Sarah Gleeson, Mary Guckian, Paul Randell, Alessia Dalla Pria, Liz Lightstone, Xiao-Ning Xu, Wendy Barclay, Stephen P. McAdoo, Peter Kelleher, and Michelle Willicombe.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-02-25
Description: The rapid implementation of SARS-CoV-2 vaccination is now a global health-care priority. Successful phase 3 trial outcomes have been reported for numerous vaccines that induce robust humoral and cellular immune responses against the SARS-CoV-2 spike…